# US 2011/0251381 A1 · Method to make steviol glycoside isomers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0251381 A1
- Document ID: US20110251381A1
- Status: Published application
- Kind: A1
- Application number: 13/092,534
- Filed: 2011-04-22
- Published: 2011-10-13
- Earliest claimed: 2007-09-17
- Assignees: PepsiCo, Inc.
- Inventors: Thomas Lee
- Web page: https://patentgrep.com/patent/US20110251381A1

## CPC

- C07H 13/08: having the esterifying carboxyl radicals directly attached to carbocyclic rings
- A23L 27/36: {Terpene glycosides}
- C07C 62/32: containing hydroxy or O-metal groups
- C07H 15/24: Condensed ring systems having three or more rings
- C07C 2603/86: containing four rings
- Y10S 426/804: Low calorie, low sodium or hypoallergic
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

Steviol glycoside isomers are provided having the formula: wherein R1 may be hydrogen, 1-β-D-glucopyranosyl, or 2-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, and R2 may be hydrogen, 1-β-D-glucopyranosyl, 2-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, 2,3-bis(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, 2-(1-α-L-rhamnopyranosyl)-1-β-D-glucopyranosyl, 2-(1-α-L-rhamnopyranosyl)-3-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, or 2-(1-β-D-xylopyranosyl)-3-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl. Methods for making steviol glycoside isomers are also disclosed. These compounds may be present in food and beverage products as non-nutritive sweeteners.

## Claims

### Claim at position 1

1-22. (canceled)

### Claim 23

A method for preparing a compound of formula II:
wherein R1 is 1-β-D-glucopyranosyl , or 2-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, and R2 is hydrogen, 1-β-D-glucopyranosyl, 2-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, 2,3-bis(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, 2-(1-α-L-rhamnopyranosyl)-1-β-D-glucopyranosyl, 2-(1-α-L-rhamnopyranosyl)-3-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, or 2-(1-β-D-xylopyranosyl)-3-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, comprising the steps of:
providing an acidic aqueous solution comprising a compound of formula I:
wherein R1 is hydrogen, 1-β-D-glucopyranosyl, or 2-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, and R2 is hydrogen, 1-β-D-glucopyranosyl, 2-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, 2,3-bis(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, 2-(1-α-L-rhamnopyranosyl)-1-β-D-glucopyranosyl, 2-(1-α-L-rhamnopyranosyl)-3-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, or 2-(1-β-D-xylopyranosyl)-3-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl; and
heating the solution to a temperature within the range of 30° C. to 90° C. for a period of time greater than two days.

### Claim 24 (depends on 23)

The method of claim 23, wherein R1 is 1-β-D-glucopyranosyl and R2 is 2,3-bis(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl in the compound of formula I.

### Claim 25 (depends on 23)

The method of claim 23, wherein the temperature is within the range of 40° C. to 50° C., and the acidic aqueous solution further comprises at least one of phosphoric acid, hydrochloric acid, nitric acid, sulfuric acid, citric acid, malic acid, tartaric acid, lactic acid, and ascorbic acid, in an amount sufficient to achieve a pH value within the range of pH 1.0-4.0.

### Claim 26 (depends on 25)

The method of claim 25, wherein the acidic aqueous solution has a pH value within the range of pH 2.0-2.5.

### Claim 27 (depends on 26)

The method of claim 26, wherein the period of time is from 2 days to 11 weeks.

### Claim 28 (depends on 23)

The method of claim 23, wherein the acidic aqueous solution further has a pH value within the range of pH 2.0-2.5

### Claim 29 (depends on 23)

The method of claim 23, wherein R1 of Formula II is 1-β-D-glucopyranosyl and R2 of Formula II is 2-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl.

### Claim 30 (depends on 23)

The method of claim 23, wherein R1 of Formula II is 2-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl and R2 of Formula II is 2,3-bis(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl.

### Claim 31 (depends on 23)

The method of claim 23, wherein R1 of Formula II is 2-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl and R2 of Formula II is 2-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl.

### Claim 32 (depends on 23)

The method of claim 23, wherein R1 of Formula II is 1-β-D-glucopyranosyl and R2 of Formula II is 1-β-D-glucopyranosyl.

### Claim 33 (depends on 23)

The method of claim 23, wherein R1 of Formula II is 1-β-D-glucopyranosyl and R2 of Formula II is 2-(1-β-D-xylopyranosyl)-3-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl.

### Claim 34 (depends on 23)

The method of claim 23, wherein R of Formula II is 1-β-D-glucopyranosyl and R2 of Formula II is hydrogen.

### Claim 35 (depends on 23)

The method of claim 23, wherein R1 of Formula II is 1-β-D-glucopyranosyl and R2 of Formula II is 2-(1-α-L-rhamnopyranosyl)-1-β-D-glucopyranosyl

### Claim 36 (depends on 23)

The method of claim 23, wherein R1 of Formula II is 1-β-D-glucopyranosyl and R2 of Formula II is 2-(1-α-L-rhamnopyranosyl)-3-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl.

### Claim 37 (depends on 23)

The method of claim 23, wherein R1 of Formula II is 2-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, and R2 of Formula II is hydrogen.

### Claim 38 (depends on 23)

The method of claim 23, wherein R1 of Formula II is 2-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, and R2 of Formula II is 1-β-D-glucopyranosyl.

### Claim 39 (depends on 23)

The method of claim 23, wherein R1 of Formula II is 2-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, and R2 of Formula II is 2-(1-α-L-rhamnopyranosyl)-1-β-D-glucopyranosyl.

### Claim 40 (depends on 23)

The method of claim 23, wherein R1 of Formula II is 2-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, and R2 of Formula II is 2-(1-α-L-rhamnopyranosyl)-3-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl.

### Claim 41 (depends on 23)

The method of claim 23, wherein R1 of Formula II is 2-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl, and R2 of Formula II is 2-(1-β-D-xylopyranosyl)-3-(1-β-D-glucopyranosyl)-1-β-D-glucopyranosyl

### Claim 42 (depends on 23)

The method of claim 23, wherein at least 1.0% by weight of the compound of formula I is converted to the compound of formula II.
